Table 4

AUC of AA and other non-invasive indices in the estimation cohort

IndexAll patientsPatients with ALT <2×ULNPatients with HBeAg negative
AUC (95% CI)SEAUC (95% CI)SEAUC (95% CI)SE
AA0.822 (0.714 to 0.930)*0.0550.845 (0.718 to 0.971)*0.0640.893 (0.779 to 0.999)*0.058
AAR0.554 (0.411 to 0.697)0.0730.566 (0.406 to 0.727)0.0820.638 (0.447 to 0.829)0.098
FIB-40.691 (0.555 to 0.827)*0.0700.643 (0.470 to 0.815)0.0880.614 (0.398 to 0.829)0.110
Forns0.687 (0.554 to 0.820)*0.0680.690 (0.534 to 0.847)*0.0800.636 (0.417 to 0.856)0.112
APRI0.707 (0.579 to 0.834)*0.0650.690 (0.546 to 0.835)*0.0740.685 (0.484 to 0.886)0.103
Fibro Q0.661 (0.517 to 0.804)*0.0730.667 (0.494 to 0.839)*0.0880.675 (0.469 to 0.882)0.105
APGA0.758 (0.635 to 0.881)*0.0630.748 (0.605 to 0.892)*0.0730.695 (0.502 to 0.887)0.098
PAPAS0.630 (0.491 to 0.769)0.0710.621 (0.462 to 0.781)0.0810.565 (0.344 to 0.786)0.113
GUCI0.729 (0.607 to 0.851)*0.0620.719 (0.583 to 0.855)*0.0690.714 (0.521 to 0.908)*0.099
RPR0.723 (0.589 to 0.858)*0.0690.703 (0.531 to 0.875)*0.0880.682 (0.466 to 0.897)0.110
GP0.671 (0.526 to 0.817)*0.0740.710 (0.546 to 0.874)*0.0840.685 (0.476 to 0.894)0.107
  • *p<0.05.

  • AAR, aspartate aminotransferase to ALT ratio; APGA, α-fetal protein index; APRI, aspartate aminotransferase to platelet ratio index; ALT, alanine aminotransferase; AUC, area under curve; FIB-4, international normalised ratio index; GP, globulin-platelet model; GUCI, Göteborg University Cirrhosis Index; HBeAg, hepatitis B e antigen; PAPAS, aspartate aminotransferase index; RPR, red cell distribution width to platelet ratio; ULN, upper limit of normal.